Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
| Conditions: | Mesothelioma |
| Start Date: | June 1, 2009 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT01204203 |
| Study Type: | Interventional |
| Intervention: | Drug: Zometa (zoledronic acid) |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University of Alabama at Birmingham|Novartis Pharmaceuticals |
| Ages: | Adult|Senior |
| Enrollment: | 19 |
| Funded By: | Other|Industry |
| First Received: | September 15, 2010 |
| End Date: | January 1, 2013 |
| Last Updated: | October 26, 2010 |
| Last Verified: | October 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
